Mazor Robotics Ltd Company Overview and Insights

Mazor Robotics Ltd has its roots in Israel, where it was founded in 1993 by Dr. Dovi Safran and Dr. Zvi Ram.

The company's headquarters is located in Caesarea, Israel.

Mazor Robotics Ltd has a strong presence in the medical robotics industry, with a focus on brain surgery and spinal surgery.

Their innovative technology has been used in over 70,000 procedures worldwide.

The company's flagship product, the Mazor X, is a robotic guidance system that helps surgeons perform complex spinal procedures with increased accuracy and precision.

This technology has been shown to reduce recovery time and improve patient outcomes.

Broaden your view: Jasic Technology Co., Ltd.

Mazor Robotics Ltd has a solid foundation in technology, thanks to Professor Moshe Shoham's invention of the SmartAssist platform. This platform was the basis for the company's initial technology.

The company's first product, SpineAssist, presented challenges such as matching pre-operative images to intraoperative CT scans and customizing the technology for different spine applications.

Mazor Robotics has filed 191 patents, which demonstrates their commitment to innovation. These patents cover a wide range of topics, including surgical robots and medical imaging.

The 3 most popular patent topics include a versatile multi-arm robotic surgical system, which was granted a patent on April 8, 2025.

Related reading: Publicly Traded Humanoid Robotics Companies

In 2016, Mazor Robotics took a significant step forward with the signing of strategic commercial and investment agreements with Medtronic, a global leader in spine technologies and solutions.

Mazor Robotics has since collaborated with Medtronic on co-marketing, promotion, and training efforts to commercialize the Mazor X platform.

These efforts have resulted in hundreds of experienced capital and clinical specialists working together to raise awareness, sell, and support Mazor X.

Mazor Robotics commercially launched Mazor X at the North American Spine Society (NASS) Annual Meeting in October 2016.

The partnership has been a game-changer for Mazor Robotics, with full year system orders increasing by 138% to an all-time record of 62 units.

Here are some key highlights of the partnership:

Mazor Robotics Ltd has a significant funding history, with a total of $6.3M raised over 5 rounds.

Its first funding round was on April 19, 2004.

The company's latest funding round was a Post IPO round on August 30, 2017, for $40M, with Medtronic being one of the investors.

Mazor Robotics has 5 institutional investors, including Medtronic, Proseed Venture Capital Fund, and Israel HealthCare Ventures.

Here's a breakdown of Mazor Robotics' funding rounds:

Mazor Robotics has a consistent funding stream from Medtronic, with the company participating in three of the company's funding rounds.

Mazor Robotics competes with other companies in the robotic-assisted surgery market. Asensus Surgical, for instance, offers products that improve surgeon control and address variability during surgical procedures.

Asensus Surgical's products utilize augmented intelligence and real-time insights, which is a significant advancement in the field. CMR Surgical, on the other hand, focuses on surgical robotics for the healthcare industry with its Versius system.

CMR Surgical's Versius system is designed for minimally invasive surgery, making it a strong competitor to Mazor Robotics. Quantum Surgical, founded in 2017, develops robotic-assisted technologies for cancer treatment in the interventional oncology sector.

Quantum Surgical's Epione platform is designed to plan, target, deliver, and confirm tumor ablation using robotics and image fusion technology. This makes it a unique offering in the market, but it's worth noting that it's a more specialized solution compared to the broader offerings of Asensus Surgical and CMR Surgical.

Intriguing read: Vaneck Robotics Etf